- Home
- ITRM vs ERNA Comparison
ITRM vs ERNA Comparison
Compare ITRM & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- ERNA
- Stock Information
- Founded
- ITRM 2015
- ERNA 2018
- Country
- ITRM Ireland
- ERNA United States
- Employees
- ITRM N/A
- ERNA N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- ITRM Health Care
- ERNA Health Care
- Exchange
- ITRM Nasdaq
- ERNA Nasdaq
- Market Cap
- ITRM 49.5M
- ERNA 56.4M
- IPO Year
- ITRM 2018
- ERNA N/A
- Fundamental
- Price
- ITRM $1.67
- ERNA $0.27
- Analyst Decision
- ITRM Strong Buy
- ERNA
- Analyst Count
- ITRM 1
- ERNA 0
- Target Price
- ITRM $5.00
- ERNA N/A
- AVG Volume (30 Days)
- ITRM 1.6M
- ERNA 2.0M
- Earning Date
- ITRM 11-14-2024
- ERNA 11-12-2024
- Dividend Yield
- ITRM N/A
- ERNA N/A
- EPS Growth
- ITRM N/A
- ERNA N/A
- EPS
- ITRM N/A
- ERNA N/A
- Revenue
- ITRM N/A
- ERNA $598,000.00
- Revenue This Year
- ITRM N/A
- ERNA N/A
- Revenue Next Year
- ITRM N/A
- ERNA N/A
- P/E Ratio
- ITRM N/A
- ERNA N/A
- Revenue Growth
- ITRM N/A
- ERNA 1072.55
- 52 Week Low
- ITRM $0.81
- ERNA $0.26
- 52 Week High
- ITRM $3.02
- ERNA $2.63
- Technical
- Relative Strength Index (RSI)
- ITRM 43.85
- ERNA 23.35
- Support Level
- ITRM $1.78
- ERNA $0.26
- Resistance Level
- ITRM $1.95
- ERNA $0.40
- Average True Range (ATR)
- ITRM 0.31
- ERNA 0.06
- MACD
- ITRM -0.11
- ERNA 0.01
- Stochastic Oscillator
- ITRM 3.23
- ERNA 4.17
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About ERNA Eterna Therapeutics Inc.
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.